Also trades as: SQZ (NYSE) · $vol 0M
SQZB OTC
SQZ Biotechnologies Company
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -14.3%
3Y: -74.4%
5Y: -99.8%
$0.02
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$84M
-1.7% ▼
Capital Expenditures
$522K
+14.8% ▲
4Y CAGR: -20.5%
Free Cash Flow
-$84M
-1.6% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$80M
-197.3% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$20M | -$32M | -$51M | -$69M | -$79M |
| Depreciation & Amort. | $1M | $4M | $11M | $11M | $12M |
| Stock-Based Comp. | $0 | $2M | $4M | $9M | $8M |
| Change in Working Capital | $39M | -$7M | -$7M | -$33M | -$24M |
| Other Non-Cash Items | $3M | -$919K | $103K | $7K | $33K |
| Operating Cash Flow | $21M | -$33M | -$43M | -$82M | -$84M |
| — Investing Activities — | |||||
| Capital Expenditures | -$1M | -$2M | -$1M | -$613K | -$522K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $34K |
| Investment Purchases | -$75M | -$116M | $0 | $0 | $0 |
| Investment Sales | $39M | $105M | $59M | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$37M | -$13M | $58M | -$613K | -$488K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $89K | $85K | -$1M | $0 | $166K |
| Financing Cash Flow | $68M | $26M | $116M | $56M | $4M |
| Net Change in Cash | $52M | -$20M | $131M | -$27M | -$80M |
| Cash End of Period | $60M | $39M | $170M | $144M | $64M |
| Free Cash Flow | $20M | -$36M | -$44M | -$83M | -$84M |